Recent decades have witnessed remarkable advancements in the treatment of muscular dystrophy. Scientists are actively exploring innovative methods that hold promise for enhancing the lives of individuals stricken by this degenerative condition. Drug development have emerged as particularly promising directions for addressing the underlying mechanis